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Abstract. The aim of the current study was to examine how belief in the validity of hallu-
cinations relates to the association between hallucination frequency and associated distress. In
a sample of inpatients with psychotic symptoms, results demonstrated that hallucination be-
lievability predicted later distress after controlling for symptom frequency. In addition, results
were consistent with the hypothesis that hallucination believability mediated the frequency-
distress link. Recent randomized controlled trials have supported the efficacy of cognitive
behavior therapy for schizophrenia and related psychotic disorders. Further evidence suggests
that cognitive behavioral approaches that incorporate mindfulness and acceptance-based
strategies may be effective in reducing the believability of positive symptoms. Future trials
incorporating longitudinal designs and more detailed assessments of these variables are needed.
Keywords: Cognitive behavior therapy, schizophrenia, psychosis, statistical mediation, clinical
trial, mindfulness, acceptance, hallucinations.
Introduction
The chronicity and severity typically associated with schizophrenia and other psychotic
disorders result in considerable distress and impairment. Randomized controlled trials of
cognitive behavior therapy (CBT) for psychosis have reported positive results in comparison
to routine care (see Gaudiano, 2005, for a review). Traditionally, assessment and treatment
procedures for psychotic patients have focused on evaluations of the frequency and severity of
symptoms such as hallucinations. With the renewed interest in adjunctive psychotherapy for
psychosis, researchers are beginning to examine a wider array of outcome and process variables
in clinical trials. For example, Chadwick and Birchwood (1994) demonstrated that patients’
beliefs about auditory hallucinations (e.g. their identity, omnipotence, purpose, control)
influenced subjective distress and subsequent behaviors. Furthermore, cognitive interventions
decreased the strength of these beliefs about hallucinations and were associated with
better outcomes.
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Most recently, clinical researchers have begun to explore the benefits of newer cognitive-
behavioral therapies that incorporate acceptance and mindfulness strategies in a variety
of clinical populations. Two preliminary trials have demonstrated the efficacy of a
mindfulness/acceptance-based intervention called Acceptance and Commitment Therapy
(ACT; Hayes, Strosahl and Wilson, 1999) for treating inpatients with psychotic symptoms
(Bach and Hayes, 2002; Gaudiano and Herbert, 2006). ACT is based on Relational Frame
Theory (RFT), a behaviorally-oriented theory and research program that applies learning
principles to the study of language and cognition. The primary assertion of RFT is that
verbally-mediated private events (e.g. cognitions, emotions, memories) do not influence
behavior directly through their content or frequency, but instead through the context in which
they occur. In contrast to the logical disputation of irrational beliefs about hallucinations in
traditional CBT, ACT encourages patients to interact with negative thoughts, feelings, and
emotions mindfully (i.e. the nonjudgemental present-focused awareness of mental events as
different from the self ), while simultaneously working toward the pursuit of valued behaviors.
In other words, whereas CBT focuses on changing thought content directly, ACT attempts
to alter the thinking process more generally, which is theorized to produce similar results in
terms of positive behavioral changes. ACT employs a variety of techniques to accomplish
this goal, including meditation and other experiential and exposure-based exercises, didactic
metaphors, cognitive “defusion” techniques, and values/goals clarification. However, the ACT
therapist refrains from disputing the validity of literal thought content directly and suggests
that patients minimize avoidance-based coping, as this can produce paradoxical effects (i.e.,
increase symptom frequency or intensity).
The aim of the current study was to examine the hypothesis that believability in
hallucinations (i.e., the degree of conviction in the validity of hallucinations) mediates the
positive relationship found between the frequency of hallucinations and the distress associated
with them. The sample was drawn from a randomized controlled trial in which inpatients with
psychotic symptoms were assessed prior to and again following either enhanced treatment as
usual (ETAU) or ETAU plus ACT during their hospitalization.
Method
Refer to Gaudiano and Herbert (2006) for a full description of the sample and procedures.
Participants were 40 currently hospitalized patients from whom informed consent was
obtained. All participants met DSM-IV criteria for a primary psychotic disorder or mood
disorder with psychotic features based on psychiatric interviews conducted by the treating
physician at admission. Average age of patients was 40 (SD = 10). The sample was
predominantly male (64%), African-American (88%), unemployed (86%), and single (88%).
Average length of stay on the unit was 11 days. As part of the larger clinical trial, patients
were randomized to ETAU (n = 21) or ETAU plus individual sessions of ACT (n = 19).
Patients received a brief ACT intervention with the number of individual treatment sessions
corresponding to their length of stay (R = 1–5; M = 3). ETAU consisted of milieu treatment
on the unit plus increased symptom monitoring and therapist contact. In ACT sessions,
participants were encouraged to increase their acceptance of the experience (not the literal
content) of psychotic symptoms, while practicing valued behavioral goals, based on a treatment
manual developed by Bach and Hayes (2002). Patients also were encouraged to minimize
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coping strategies aimed at avoiding or disputing hallucination-related content directly and to
notice the transient nature of symptoms.
Participants were asked to rate separately the frequency, believability, and distress associated
with their hallucinations using a Likert-scale format (adapted from Bach and Hayes, 2002).
Regarding frequency of hallucinations, participants were asked: “On average, how often have
you heard voices in the month prior to admission?” 1 = never; 2 = less than once a week; 3 =
about once a week; 4 = several times a week; 5 = daily; 6 = more than once a day; 7 = almost
constant. Regarding believability of hallucinations, participants were asked: “On a scale from
0 to 10, how much do you believe that (specific hallucination) is real or true? Zero means that
you are certain it is not real or true, and 10 means you are absolutely certain that it is real
or true”. In the current study, believability was conceptualized as a rating of the validity of
hallucinations in general, in contrast to specific beliefs about the nature of hallucinations (e.g.
the “identity” or perceived omnipotence of the voice). For example, one patient experienced
an auditory hallucination in which his deceased father would call him an “evil” person. In
this case, the question would be: “On a scale from 0 to 10, how much do you believe that
the voice of your father telling you that you are an evil person is real or true?” Regarding
distress associated with hallucinations, participants were asked: “On a scale from 0 to 10, how
bothered are you by (specific hallucination)? Zero means not distressed at all and 10 means the
most distressed you’ve ever been.” Ratings were taken shortly after admission to the hospital
and then again prior to discharge.
Results
See Gaudiano and Herbert (2006) for a description of results from the clinical trial. Twenty-
nine participants had complete assessment data at pre- and post-treatment. Only one participant
from each group actually withdrew from the study. Rates of missing post-treatment data due to
unexpected discharge from the hospital did not differ between groups (ETAU n = 5; ETAU +
ACT n = 4). An analysis was conducted to determine if believability of hallucinations predicted
associated distress beyond the variance accounted for by the frequency of hallucinations (see
Table 1). Pearson r correlations between variables were all significant, positive, and moderate
in magnitude (all ps < .05). A hierarchical multiple regression analysis was conducted entering
relevant demographic variables (gender, age, and psychotic vs. mood disorder) first, pre-test
hallucination frequency second (M = 4.9, SD = 2.3), and pre-test hallucination believability
third (M = 7.0, SD = 3.3) to predict post-test hallucination-related distress (M = 6.7, SD =
3.2). Hallucination frequency significantly predicted distress prior to the inclusion of the
believability rating (p = .01), such that higher hallucination frequency at pre-test predicted
higher distress at post-test. However, in the final model, only diagnostic status (p < .05)
and hallucination believability (p < .01), but not frequency (p = .57), significantly predicted
distress. Specifically, a diagnosis of a primary psychotic disorder (versus mood disorder with
psychotic features) and higher hallucination believability at pre-test predicted higher distress
at post-test.
An analysis was conducted to examine whether believability in hallucinations was acting as a
mediator in the relationship between frequency of hallucinations and associated distress. Based
on recommendations by Baron and Kenny (1986), three independent regression equations
were computed: regressing the mediator (i.e. believability) on the independent variable (i.e.
frequency); regressing the dependent variable (i.e. distress) on the independent variable; and
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Table 1. Hierarchical multiple regression analysis using pre-test variables to predict post-test
distress associated with hallucinations
Coefficients
Predictors Standardized Unstandardized t p
Equation #1
Gender −.19 −1.21 −.99 .33
Age .20 .06 1.07 .30
Diagnosis −.13 −.83 −.67 .51
Equation #2
Gender −.24 −1.48 −1.38 .18
Age .19 .06 1.17 .25
Diagnosis −.20 −1.24 −1.14 .27
Hallucination frequency .49 .74 2.93 ∗.01
Equation #3
Gender −.25 −1.55 −1.74 .10
Age .16 .05 1.14 .27
Diagnosis −.33 −2.07 −2.21 ∗.04
Hallucination frequency .10 .16 .58 .57
Hallucination believability .64 .65 3.46 ∗.00
Note: ∗ = significant result. Equation #3: F5, 23 = 5.97, p < .01, R2 = 0.57.
regressing the dependent variable on both the independent and mediator variables. Mediation
occurs if the first two regressions are significant, and in the third equation, the strength of the
relationship between the independent and dependent variables is decreased by the inclusion
of the mediator. The following self-report measures were used in the analyses: hallucination
frequency over the past month (retrospectively assessed at pre-test), current distress associated
with these hallucinations (assessed at pre-test), and post-test distress associated with these
hallucinations.
All the above conditions were met. Frequency of hallucinations over the past month
significantly predicted pre-test believability of hallucinations (β = .69, t = 5.96, p < .01).
Frequency also predicted post-test distress about hallucinations (β = .44, t = 2.55, p < .05).
Finally, believability (β = .52, t = 2.56, p < .05) but not frequency of hallucinations (p = .61)
predicted associated distress (F2, 26 = 7.19, p < .01). Testing the standard error of the indirect
effect using the Sobel test indicated that believability mediated the relationship between
frequency of hallucinations and associated distress (t = 2.35, p = .05). These results are
consistent with the hypothesis that the frequency of hallucinations is associated with distress
based on the strength of believability in them.
A similar mediation analysis was conducted to test whether hallucination frequency was
a potential mediator of believability and distress. These conditions were not met; pre-
test hallucination believability did not predict pre-test frequency (p = .35), and pre-test
hallucination frequency (p = .61) was not a significant predictor of post-test distress in the
context of hallucination believability.
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Discussion
As expected, pre-test hallucination frequency predicted later distress associated with
hallucinations. However, results revealed that hallucination believability predicted unique
variance beyond that accounted for by symptom frequency alone and the other covariates.
Furthermore, results were consistent with the hypothesis that the believability of hallucinations
at least partially mediated the positive association between symptom frequency and related
distress. Results suggest the importance of targeting not only the frequency of psychotic
symptoms in treatment, but also, and perhaps even especially, the patient’s relationship to
them. Psychotherapies for psychosis, such as traditional CBT and newer CBT approaches
that emphasize acceptance and mindfulness, may be particularly helpful in targeting not only
symptom frequency, but other related psychological mediators of distress, such as beliefs about
symptoms (see Chadwick and Birchwood, 1994).
Even though results in the present study were consistent with the hypothesis that believability
mediated the relationship between symptom frequency and distress, conclusions are tempered
by study limitations. It is important to note that ratings were face valid and could have
been subject to demand characteristics. In addition, participants were asked to report
hallucination frequency in the past month retrospectively in the current study. In order to test
mediation fully, the temporal relationship between variables must be clearly demonstrated.
Furthermore, because participants were receiving different treatments between assessment
points, it is unclear whether results pertain to ACT specifically, patients receiving treatment
in general, or patients with psychotic symptoms more broadly. An attempt was made to
conduct mediation analyses separately by treatment group, but neither set of analyses reached
statistical significance for all conditions, probably due to low power. Finally, self-report
ratings in the current study assessed believability in a general sense, and it is unclear how
this related to more specific beliefs about hallucinations (e.g. their perceived identity or
purpose).
Other sources of data may be helpful to consider in the context of the current findings.
Bach and Hayes (2002) reported that ACT produced greater reductions in self-reported
believability in psychotic symptoms relative to treatment as usual in psychotic inpatients. In
a replication study by Gaudiano and Herbert (2005), only the ACT group showed significant
improvements in hallucination believability over time. Furthermore, decreases in hallucination
believability, but not frequency, predicted decreases in distress over the course of treatment
in the ACT but not ETAU only condition. Teasdale and colleagues (2002) demonstrated that
increased metacognitive awareness (i.e. the degree to which individuals experience negative
thoughts/feelings as mental events rather than as the self ) predicted relapse in recovered
depressed patients treated with either mindfulness-based or traditional cognitive therapy
(Teasdale et al., 2002). Such evidence suggests that results from the current study may be
most applicable to patients in treatment.
Future outcome trials should continue to examine and target symptom believability,
frequency, and distress in persons with psychosis using longitudinal designs and a broader
range of psychometrically-sound instruments to identify other potential psychological
mediators. For example, one potentially useful scale for this purpose would be the Psychotic
Symptom Rating Scales (PSYRATS; Haddock, McCarron, Tarrier and Faragher, 1999),
which assess various dimensions of psychotic symptoms (e.g. beliefs about the origins of
voices).
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